A detailed history of Group One Trading, L.P. transactions in Vaxart, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 84,406 shares of VXRT stock, worth $59,928. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,406
Previous 60,406 39.73%
Holding current value
$59,928
Previous $78,000 28.21%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.53 - $1.3 $12,720 - $31,200
24,000 Added 39.73%
84,406 $56,000
Q1 2024

May 10, 2024

SELL
$0.56 - $1.41 $12,518 - $31,520
-22,355 Reduced 27.01%
60,406 $78,000
Q4 2023

Feb 14, 2024

BUY
$0.57 - $0.85 $56 - $85
100 Added 0.12%
82,761 $47,000
Q3 2023

Nov 09, 2023

BUY
$0.69 - $0.85 $12,212 - $15,045
17,700 Added 27.25%
82,661 $61,000
Q2 2023

Aug 09, 2023

BUY
$0.6 - $1.41 $2,940 - $6,909
4,900 Added 8.16%
64,961 $47,000
Q1 2023

May 12, 2023

BUY
$0.71 - $1.25 $4,408 - $7,761
6,209 Added 11.53%
60,061 $45,000
Q4 2022

Feb 09, 2023

SELL
$0.75 - $2.24 $9,000 - $26,880
-12,000 Reduced 18.22%
53,852 $51,000
Q3 2022

Nov 09, 2022

BUY
$2.09 - $4.5 $7,808 - $16,812
3,736 Added 6.01%
65,852 $144,000
Q2 2022

Aug 11, 2022

SELL
$2.7 - $5.28 $177,244 - $346,610
-65,646 Reduced 51.38%
62,116 $217,000
Q1 2022

May 12, 2022

BUY
$4.29 - $6.64 $327,481 - $506,871
76,336 Added 148.44%
127,762 $644,000
Q4 2021

Feb 11, 2022

BUY
$5.77 - $7.96 $138,087 - $190,498
23,932 Added 87.04%
51,426 $322,000
Q3 2021

Nov 12, 2021

SELL
$6.67 - $9.8 $663,118 - $974,296
-99,418 Reduced 78.34%
27,494 $219,000
Q2 2021

Aug 10, 2021

BUY
$5.06 - $10.78 $473,813 - $1.01 Million
93,639 Added 281.43%
126,912 $951,000
Q1 2021

May 12, 2021

BUY
$5.64 - $23.33 $187,659 - $776,259
33,273 New
33,273 $201,000
Q4 2020

Feb 10, 2021

SELL
$3.5 - $7.98 $392,602 - $895,132
-112,172 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$4.78 - $16.97 $536,182 - $1.9 Million
112,172 New
112,172 $746,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $89.8M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.